All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
| Wed 1984-11-07? to Tue 2025-03-25 |
YTD
Return |
TRR
Price |
||||
|---|---|---|---|---|---|---|
| TEVA × |
−29.66%
2025-03-25 |
127.33 TRR
2025-03-25 |
||||
| Teva Pharma Industries Ltd ADR NYSE Common Stock | ||||||
Date | -- |
|---|---|
TEVA | -- |
TEVA (Trendline) | -- |
| Wed 1984-11-07? to Tue 2025-03-25 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| TEVA × |
+12,633.17%
+12.75%/yr |
+9.59%/yr
(R2=0.495) |
||||
| Teva Pharma Industries Ltd ADR NYSE Common Stock | ||||||
| Wed 1984-11-07? to Tue 2025-03-25 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| TEVA × |
$10,000.00
1984-11-07 |
$1,273,317.11
2025-03-25 |
||||
| Teva Pharma Industries Ltd ADR NYSE Common Stock | ||||||
| Year | TEVA |
|---|---|
| 2025 (YTD) | −29.66% |
| 2024 | +105.15% |
| 2023 | +10.77% |
| 2022 | +6.94% |
| 2021 | −22.42% |
| 2020 | −2.87% |
| 2019 | −37.87% |
| 2018 | −20.15% |
| 2017 | −47.08% |
| 2016 | −44.35% |
| 2015 | +15.86% |
| 2014 | +46.24% |
| 2013 | +9.28% |
| 2012 | −6.75% |
| 2011 | −23.33% |
| 2010 | −7.27% |
| 2009 | +30.07% |
| 2008 | −7.44% |
| 2007 | +45.04% |
| 2006 | −28.91% |
| 2005 | +40.46% |
| 2004 | +2.69% |
| 2003 | +45.16% |
| 2002 | +23.06% |
| 2001 | −16.76% |
| 2000 | +100.08% |
| 1999 | +72.32% |
| 1998 | −14.83% |
| 1997 | −7.01% |
| 1996 | +5.95% |
| 1995 | +89.40% |
| 1994 | −20.72% |
| 1993 | +34.52% |
| 1992 | +127.32% |
| 1991 | +60.84% |
| 1990 | −6.57% |
| 1989 | +65.72% |
| 1988 | +6.02% |
| 1987 | −6.59% |
| 1986 | +122.24% |
| 1985 | +167.91% |
| 1984 | +6.16% |
Date | -- |
|---|---|
TEVA | -- |
| Wed 1984-11-07? to Tue 2025-03-25 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| TEVA × | −82.51% |
−91.75%
2022-07-11 |
||||
| Teva Pharma Industries Ltd ADR NYSE Common Stock | ||||||